Circulating exosomal microRNAs offer a non-invasive biomarker for MASLD
Metabolic dysfunction-associated steatotic liver disease (MASLD) has become a global public health challenge with rapidly rising prevalence, especially…
New roadmap links liver cancer biology to immunotherapy and precision medicine
A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona…
Rat hepatitis E virus may be a hidden cause of hepatitis in humans
A growing body of evidence suggests that rat hepatitis E virus is spilling into humans more often than…
EV-RNAs show promise for IBD diagnosis and treatment
A research team led by Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, has published a comprehensive…
New blood test spots four cancers and other diseases by stripping away healthy DNA noise
By cutting through the overwhelming background of healthy blood DNA, MethylScan gives clinicians a clearer view of cancer,…
Higher sugar intake raises gallstone risk in adults, study finds
Researchers analyzing recent NHANES data found that adults with higher total sugar intake had greater odds of gallstones,…
Ultrasound advances offer noninvasive assessment of portal hypertension severity
Portal hypertension (PH), a serious complication of liver cirrhosis, is defined as a pressure gradient > 5 mmHg…
Molecular test shows high sensitivity in detecting bile duct cancer
When patients develop a narrowing or blockage in the bile ducts – the tubes connecting the liver, gallbladder…
New algorithm enables precise subtyping of metabolic liver disease
Metabolic-associated steatotic liver disease (MASLD) is a clinically heterogeneous condition with highly variable outcomes affecting more than 30%…
Machine learning model predicts liver cancer risk with high accuracy
Bottom line: A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test…
Patients who stop GLP-1 drugs often restart or try alternatives
A large real-world study shows that patients who stop popular GLP-1–based weight-loss drugs often return to treatment or…
Study links heavy metals, ‘hidden drugs’ in alt meds to liver injury. Safety, regulation debate grows
Published in Frontiers in Gastroenterology—an open-access research in digestive health, liver disease, infections, cancer and gastrointestinal care—the study…